Skip to main content

ASCIA News

  • Product Update - Anapen® Adrenaline Injector Devices
    Arrotex Pharmaceuticals has advised that the sale and distribution of Anapen® Junior 150 and Anapen® 300 used for the emergency treatment of anaphylaxis are to cease in Australia: Anapen® 300 will be available until end July 2024. Anapen® Junior 150 will be available until...
  • ASCIA 2024 Conference Earlybird Registration and Abstract Submission - Deadline extended to 8 July
    In response to several requests, the deadline for ASCIA 2024 Conference discounted earlybird registration and abstract submission has been extended to next Monday 8th July 2024. Please note that no further extensions are possible. To register go to...
  • ASI Clinical Translation School 2024
    The second ASI Clinical Translation School will be held at Q Station in Manly, Sydney from Wednesday 18th to Friday 20th September 2024. This in-person intensive 2-day School will host an expert line-up of clinical translation speakers, and an engaged network of...
  • Updates to Australian medicine labelling rules to support medicine safety
    The Therapeutic Goods Administration (TGA) public consultation is now open on Updates to Australian medicine labelling rules to support medicine safety to seek feedback to make sure proposed changes to labelling rules support the safe use of medicines. The TGA is proposing...
  • Arexvy® RSV Vaccine
    ASCIA has submitted a letter of support for the Arexvy® Respiratory Syncytial Virus (RSV) Vaccine application for new National Immunisation Program (NIP) listing (lodged 29 May 2024) which is available at https://www.allergy.org.au/ascia-submissions  Respiratory Syncytial Virus (RSV) recombinant subunit vaccine...
  • Food Allergy Week 2024 - When eating out, always ask, always tell
    Food Allergy Week 2024 runs from 26 May to 1 June, and is an initiative of Allergy & Anaphylaxis Australia, the national patient/carer support organisation. The theme for Food Allergy Week 2024 is 'When eating out, always ask, always tell'. The risk of an allergic reaction...
  • ASCIA Anaphylaxis e-training for Schools and Childcare Reports
    For the first time since ASCIA e-training courses for Schools and Children’s Education/Care (CEC) were introduced in 2010, reports have been developed based on mandatory feedback surveys in the Australasian versions of the courses. The surveys were completed by 43,945...
  • ASCIA Anaphylaxis e-training for Health Professionals Reports
    For the first time since ASCIA e-training for health professionals was introduced in 2011, reports have been developed based on mandatory feedback surveys. These surveys were completed by 1,730 health professionals and the reports are available here Highlights from the...
ASCIA Member Login

Site last updated: 11 Jun 2024
 

ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.

Join our mailing list or see latest edition here...